Work

A phase II study of capecitabine (Cape) or 5-fluorouracil (5-FU) with pegylated interferon alpha-2b (Peg-IFNA-2b) in unresectable/metastatic cutaneous squamous cell carcinoma (CSCC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e21020

Authors: Jameel Muzaffar, Nikhil I. Khushalani, Jeffery Scott Russell, Janaki Parameswaran, Kedar Kirtane, Janis De La Iglesia, Robbert Slebos, Christine H. Chung

Institution: Moffitt Cancer Center

Language: English

Topic: Nonmelanoma Skin Cancer Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947598171

Cites:

Cited by:

Related to: 10